Multiple oncology drugs receive FDA or TGA approvals
ABBVORCA
Statements (7)
- Bullish
US FDA approves Orca Bio's blood cancer therapy
- Neutral
AbbVie received FDA approval for a rare cancer therapy
- Bullish
US FDA approves AbbVie's rare blood cancer drug
- Neutral
OncoSil Medical received TGA approval for its OncoSil device for treating locally advanced pancreatic cancer.
- Bullish
BeOne Medicines received conditional FDA approval for cancer drug BEQALZI for post-BTK mantle cell lymphoma.
- Neutral
Taiho Oncology received FDA regulatory approval for a cancer drug in the haematological space.
- Neutral
BeOne Medicines received FDA regulatory approval for a cancer drug in the haematological space.